Introduction
A critical factor in the host immune response to invading pathogens, such as viral infections, is the recruitment and infiltration of immune cells to infected tissues. Although the goal of the recruited leukocytes is to eliminate the invading pathogens, collateral tissue damage may be induced in the process, and, in certain circumstances, may pose a serious threat to the survival of the host. The central nervous system (CNS) is a unique site with limited regenerative potential and therefore a low threshold for inflammation-induced tissue damage. However, as the CNS may become the target of life-threatening viral infections, it is imperative that immunological surveillance and efficient effector responses occur in this organ to aid in pathogen clearance. Although traditionally characterized as a site of "immune privilege," evidence suggests that immune surveillance and antiviral immunity does occur in the CNS (Carson et al., 2006) . Understanding how the local inflammatory response within the CNS is regulated is a key to understanding the pathogenesis of viral infections in the CNS and developing therapies that promote protective and limit pathogenic responses. Leukocyte recruitment to any organ site is generally a complex, multistep process. Under normal conditions, leukocyte migration into the CNS is maintained at low levels (Hickey, 2001) . During virus-induced inflammation, however, the extravasation of leukocytes is increased and targeted to specific compartments of the CNS depending on the inflammatory stimulus and the infected region. Chemokines and chemokine receptors have been identified as pivotal players in regulating immune cell trafficking into the CNS. Chemokines consist of a large family of small, structurally related, chemotactic cytokines that are involved in regulating the normal lymphocytic traffic to both the lymphoid and nonlymphoid organs and leukocyte emigration into sites of injury and infection (Rossi & Zlotnik, 2000) . Chemokines select leukocytes for tissue entry based on their expression of chemokine receptors, G-protein-coupled cell surface receptors, which have a characteristic seven transmembrane structure (Premack & Schall, 1996) . In addition to targeting distinct leukocyte populations during inflammation, chemokines and their receptors have emerged as crucial mediators of a variety of biological processes including development and tissue homeostasis. With regard to virus-induced inflammation in the CNS, chemokines and chemokine receptors are in a strategic position to coordinate immune responses through both the regulation of leukocyte extravasation and also in the final positioning and activation of infiltrating cells. Immune surveillance of the CNS and the effector function of infiltrating leukocytes into the CNS dictate the host-pathogen relationship during viral pathogenesis of the CNS. The increased viral burden occurs (Lim et al., 2010) . Monocytosis occurs following WNV infection in WT mice and peaks just before monocytes begin to traffic into the brain (Lim & Murphy, 2011 ). This appears to be dependent on CCR2 since the numbers of recruited CD4 + and CD8 + T cells and NK cells in the brain of CCR2 knockout mice following WNV infection are similar to wild-type mice, whereas, the accumulation of inflammatory monocytes in the CNS is severely deficient. Thus, monocytes may be beneficial or harmful depending on the infection model. Studies of WNV infection in five week-old WT mice, which exhibit a 10-20% survival rate, indicated that impaired viral clearance and survival may be partially due to lack of migration of antiviral CD8 + T cells into the CNS parenchyma. Normally, infiltrating T cells are retained in perivascular spaces through the interaction of CXCR4 with its ligand CXCL12, which is found along abluminal surfaces of the entire CNS vasculature (McCandless et al., 2006; McCandless et al., 2008) . Following WNV infection in eight weekold mice, CXCL12 levels decline by day two post-infection, allowing egress of antiviral T cells (Durrant, unpublished data) . In contrast, five week-old mice do not exhibit downregulation of CXCL12 until eight days post-infection, which is associated with perivascular accumulation of CXCR4-expressing T cells and increasing numbers of WNV-infected neurons. These data suggest that developmental changes in regulation of CXCL12 expression at the blood-brain barrier may contribute to antiviral immune responses. In support of a critical role for CXCL12 in limiting egress of virus-specific CD8 + T cells, administration of the specific CXCR4 antagonist, AMD3100, was associated with increased migration of effector T cells into the CNS and enhanced viral clearance (McCandless et al., 2008) . CXCR4 antagonism was also associated with a rapid decrease in immune cell trafficking as virologic control ensued, suggesting that an early increase in virus-specific immune cell trafficking that controls viral infection ultimately leads to a rapid dampening of inflammation that would otherwise have pathologic consequences. Taken altogether, these studies support a role for chemokines in the final positioning of effector cells that dictates outcome of immune responses in response to viral invasion within the CNS. Since resolution of CNS infection is often a balance between immune-mediated pathogen clearance and the deleterious effects of inflammation, studies utilizing the murine WNV encephalitis model suggest that if the appropriate cells reach critical regions at the appropriate time, virologic control may be accomplished and less severe disease occur.
CCR5 in human WNV disease
Studies of patients that carry a 32 base-pair deletion within the coding sequence of CCR5 (CCR5Δ32) indicate that human CCR5 is important in WNV pathogenesis. A genotypephenotype association study of patients carrying CCR5Δ32, who lack functional CCR5, suggested that WNV-infected CCR5Δ32 homozygous individuals exhibit higher incidences of symptomatic infection. Ultimately, CCR5 deficiency resulted in 100% susceptibility to severe symptomatic disease (Glass et al., 2006) . This genetic deficiency supports the observations in the WNV mouse model that functional CCR5 is critical for viral control and disease progression.
JEV
Japanese encephalitis virus (JEV) is a mosquito borne pathogen that occurs throughout most of Asia. JEV causes infection of the CNS with a high mortality rate (Parida et al., 2006) .
www.intechopen.com
Clinical manifestation of JEV include fever, headache, vomiting, altered consciousness, and severe meningo-encephalitis (Kumar et al., 1990) . Children appear to be at greatest risk of infection in endemic areas for unknown reasons. Following entry into the host, JEV generates a rapid inflammatory response, which results in infiltration of neutrophils into the CNS. JEV is highly neurotropic, infecting neuronal rather than non-neuronal tissues in humans (Vaughn & Hoke, 1992) with neuronal precursors as the major target cells for infection (Kimura-Kuroda et al., 1993) . The course of disease for JEV in humans is faithfully replicated in murine models. Following extraneural inoculation with JEV, young mice are highly susceptible to neuroinvasion and rapidly die soon after virus is detected within the CNS (Johnson et al., 1985; Hase et al., 1990) . Thus, viral titers of JEV in the brain generally peak at five days post-infection with death occurring between five and six days postinfection.
Chemokines and JEV-associated encephalitis
Expression of the chemokines CXCL10 and CXCL1 is upregulated in neuroblastoma cells infected with JEV (Gupta et al., 2010) . In a JEV-infected mouse model, similar chemokines were significantly upregulated including CXCL9, CXCL10 and CXCL12 (Gupta et al., 2010) . In addition to the robust expression of proinflammatory chemokines there was also increased numbers of infiltrating inflammatory cells into the brain at day five post-infection. Similar to WNV, JEV-infected neurons were found to be the source of CXCL10. CCL5 was also detected in JEV-infected neuroblastoma cells, indicating a possible role for this chemokine in the early stages of infection. Interestingly, neuronal death and mortality rate increases in patients with elevated levels of proinflammatory cytokines and chemokines, including CCL5, in the serum and cerebrospinal fluid (Winter et al., 2004) . Whether this is simply correlative data or whether these chemokines actually contribute to pathogenesis is currently unknown. An improved understanding of the proinflammatory effects responsible for immune-mediated control of viral infection and neuronal injury during JEV infections is essential to determine the viral pathogenesis of JEV in the CNS.
TBEV
Tickborne encephalitis virus (TBEV) is an additional member of the Flaviviridae family that causes Tickborne encephalitis (TBE), a severe infection of the CNS. TBEV is usually transmitted to patients by infected Ixodes ricinus ticks (Gunther & Haglund, 2005) . Infection with TBEV is characterized by a biphasic clinical course with early nonspecific influenza-like symptoms and subsequent development of neurological symptoms or meningoencephalitis (Haglund & Gunther, 2003; Holzmann, 2003) . In most fatal cases, TBEV can be found in the brain tissue (Gelpi et al., 2005 ). An animal model for TBEV has not been established to date. The pro-inflammatory cytokines CCL2, CCL5, CXCL10 and CXCL11 have been detected in the CSF of TBE patients Lepej et al., 2006; Michalowska-Wender et al., 2006) . Although these chemokines exhibit known anti-viral roles in WNV encephalitis, their specific role in TBE is yet to be fully determined. One significant study, however, demonstrated an association between carriage of the CCR5Δ32 allele and TBE (Kindberg et al., 2008) . Similar to WNV, an association between severe TBE and CCR5Δ32 homozygosity was observed. Therefore, loss of CCR5 function in humans is a risk factor for TBE in patients exposed to TBEV. Increased expression of CCL5 in the CSF of patients with TBE suggests it may indeed play a role in leukocyte trafficking within TBEV-infected patients. Thus, CCR5 may be essential for limiting viral replication within the CNS through effective antiviral immune responses that shorten the course and limit the lethality of encephalitis.
HSV
Herpes simplex virus (HSV) types 1 and 2 establish latent infection in dorsal root ganglia for the entire life of the host. From this reservoir they can reactivate to cause human morbidity and mortality. HSV-1 is the causative agent of encephalitis and several disorders of the peripheral nervous system. HSV-2 is responsible for meningitis in neonates and in adults (Steiner et al., 2007) . HSV encephalitis is considered the most frequent cause of sporadic encephalitis in North America (Whitley, 1981) . In a murine model of HSV-1 infection, the intracranial inoculation of a neurotropic HSV-1 strain causes encephalitis and death by day six after infection (Vilela et al., 2008) . In a murine model of HSV-2 infection, intraperitoneal inoculation with a neurovirulent HSV-2 strain causes meningoencephalitis (Kristensson et al., 1978) and death occurs 10-14 days after infection. Pathology of HSV-2 infection has been shown to be T-cell mediated, due specifically to the actions of Th2 cells (Ikemoto et al., 1995) .
Chemokines and HSV
Following intracranial inoculation of HSV-1, early chemokine expression is dominated by CCL2, CCL3, CCL5, CXCL9 and CXCL10 (Wickham et al., 2005; Carr et al., 2006) . CCL2, in particular, exhibits an important role in the early immune response to CNS infection with HSV-1 as monocyte recruitment to the CNS is significantly diminished in mice with targeted deletion of CCL2, thus hindering viral clearance (Kodukula et al., 1999) . CXCR3-deficient mice similarly exhibit elevated CNS viral titers of HSV-1, but only on day seven postinfection. Interestingly, survival was enhanced in CXCR3-deficient mice compared with wild-type mice following HSV-1 infection (Wickham et al., 2005) , suggesting a more complex role for CXCR3. Coinciding with increased viral titer, protein levels of CCL5, CXCL9, CXCL10 and IFN-were increased in the CNS as well as CD8 + lymphocytes, suggesting a role for this receptor in antiviral adaptive immunity. In the absence of CXCR3, a transient increase in viral burden facilitates an elevated protective immune response. In HSV-1-infected, CCR5-deficient mice, viral load was decreased in the CNS but associated with greater neuropathology and increased lethality (Teixeira et al., 2010) . Following infection, CCR5-deficient mice exhibited increased chemokine levels, including CCL5 and CCL2; enhanced expression of cytokines, such as TNF-α; and a significant increase in leukocyte migration into the brain (Teixeira et al., 2010) . Thus, in the absence of CCR5, greater control of viral replication was achieved, but at the cost of enhanced neuropathology and ultimately death. Generally, CCR5 deficiency would lead to decreased leukocyte infiltration; therefore, these results are surprising and may be unique to HSV-1 encephalitis. Treatment with anti-CCL5 antibodies or with small molecule antagonists of CCR1 and CCR5, both CCL5 receptors, had no effect on viral titers but led to significant reduction of the number of leukocytes infiltrating into the brain . Therefore, blocking CCR1 and CCR5 did not affect HSV-1 replication, suggesting that other immune mechanisms are involved in the process of viral control. CCL2 has been identified as an initiator of Th2 responses and has a pathogenic role in the development of disease in HSV-2-infected mice (Karpus et al., 1997; Hogaboam et al., 1998) . In the absence of CCL2 the severity of disease decreased dramatically, and the amount of Th2 cytokine production also decreased (Nakajima et al., 2001 ). It appears that a population of macrophages in mouse CSF is the primary producers of CCL2, which are postulated to increase severity of disease through induction of Th2 responses. Of note, CCL2 has been detected in the CSF from patients with herpes simplex encephalitis and has been correlated with clinical severity of herpes simplex encephalitis (Rosler et al., 1998) .
LCMV
Lymphocytic choriomeningitis virus (LCMV) is spread by the common house mouse and can cause aseptic meningitis in children and adults, neurological dysfunction in newborns and may induce spontaneous abortion in pregnant women (Enders et al., 1999) . Infection with LCMV can present with two separate clinical phases. Symptoms of the first phase include fever, malaise, headache and nausea, which resolve after several days and are then followed by the second phase of illness, which is characterized by symptoms of meningitis (Bonthius, 2009 ) with an abundant number of lymphocytes within the CSF (Chesney et al., 1979) . Although recovery from CNS disease is common, severe neurological disease as well as death, although rare, may occur. Congenital infection with LCMV is often fatal for the fetus or newborn (Biggar et al., 1975) . Survivors of congenital LCMV infection usually experience severe visual and cognitive impairment (Barton et al., 1995) . LCMV infection of the brain parenchyma may extend specifically to neuronal precursor cells, especially in prenatal or neonatal infections (Bonthius et al., 2007) . LCMV is essentially a noncytolytic virus (Hotchin & Weigand, 1961) and in murine models of LCMV-induced meningoencephalitis (LCM), intracranial infection of LCMV into healthy adult mice results in fatal meningitis between seven and ten days after viral infection (Cole et al., 1972; . Symptoms of disease are accompanied by a massive infiltration of mononuclear cells into the meninges, choroid plexus, CSF, and ependymal membranes Buchmeier et al., 1980; Ceredig et al., 1987; Doherty et al., 1990) . CD8 + T cells and macrophages dominate the cellular infiltrate Ceredig et al., 1987) , whereas CD4 + T cells and polymorphonuclear leukocytes are present in limited numbers (Ceredig et al., 1987; Dixon et al., 1987; Christensen et al., 1995) . It appears that the T cell response is a critical component for LCM because lethal meningitis does not occur in immunodeficient (irradiated or T-cell-depleted) mice following intracranial infection Christoffersen et al., 1976) . Moreover, in the absence of CD8 + T cells, mice will invariably survive intracranial LCMV infection (Christoffersen et al., 1976; Leist et al., 1987) , suggesting that virus-specific CD8 + cytotoxic T lymphocytes mediate fatal tissue damage (Buchmeier et al., 1980; Doherty et al., 1990) . The role of virus-specific CD8 + T cells during lethal LCM appears to be dependent on the strain of virus. Mice infected with the Armstrong strain of LCMV leads to killing of virus-infected cells in the meninges via a perforin-dependent mechanism (Kagi et al., 1994) , which leads to increased immunopathology. Whereas, mice infected with the Traub strain of LCMV exhibit lymphocytic infiltration of the neuroparenchyma rather than meningeal inflammation, which leads to a more fatal outcome (Christensen et al., 2004) . Overall, pathogenesis and death may be directly related to the influx of virus-specific T cells into critical regions of the CNS.
Chemokines and Lymphocytic choriomeningitis
During the mouse model of LCMV infection, expression of the T cell chemoattractants CCL2, CCL4, CCL5 and CCL7 as well as CXCL9, CXCL10 and CXCL11 is detected in the virus-infected tissues, as well as in the meninges, as early as day three post-infection (Asensio & Campbell, 1997; Nansen et al., 2000; Nansen et al., 2002; Lindow et al., 2003) . On days six to seven post-infection, expression of these chemokines is significantly increased and accompanied by increased expression of granulocyte chemoattractants including XCL1 and CXCL2, CXCL6, CXCL16, and CCL3 (Asensio & Campbell, 1997; Nansen et al., 2000) . The main chemokine-producing cell types are resident cells of the CNS, particularly the meninges and choroid plexus together with astrocytes (Loetscher et al., 2001) . This surge of chemokine activity coincides with immune cell infiltration into the infected tissue. An analysis of chemokine receptor expression revealed local expression of receptors for these chemokines including CCR1, CCR2 and CCR5 as well as CXCR3 around day six to seven post-infection. (Nansen et al., 2000; Lindow et al., 2003) . The analyses of cells from the inflammatory exudate of LCMV-infected mice indicate that T cells express CCR2, CCR5, and CXCR3, whereas macrophages are the predominant cell type expressing CCR1 (Nansen et al., 2000; Lindow et al., 2003; Christensen et al., 2004) . Thus, the elevated expression of these chemokines and chemokine receptors is likely to result in T lymphocytic and macrophage infiltration to the inflammatory site. The chemokines CXCL9, CXCL10 and CXCL11 are the three known ligands for the receptor CXCR3 (Loetscher et al., 2001) . CXCL10 is rapidly upregulated in the virus-infected CNS (Asensio et al., 1999; Nansen et al., 2000) , which results in the recruitment of CXCR3 + cells into critical regions of the CNS. CXCL9 and CXCL11 are also expressed, but their role appears to be redundant (Christensen et al., 2006) . The majority of cells found to be expressing CXCR3 were activated IFN--producing CD8 + T cells (Homann et al., 2001; Christensen et al., 2004) . A strong positive feedback loop is established through the local production of IFN-, which brings about further, marked upregulation of CXCL10 expression and therefore continued recruitment of CXCR3 + effector cells. This robust recruitment positions CXCL10 as a key mediator of severe LCMV-induced CNS disease. In the absence of CXCL10, approximately half of LCMV (Traub) intracranially infected mice are protected from a lethal viral dose (Christensen et al., 2006) . CXCL10-deficient mice show no impairment of effector T cell generation or of immune cell infiltration, except for reduced CD8 + T cell accumulation in parenchymal regions such as the corpus callosum (Christensen et al., 2006) . On the other hand, CXCL10 appears to be dispensable for the development of fatal neuroinflammation following infection with LCMV (Armstrong) (Hofer et al., 2008) . This highlights that there are underlying differences in viral strains and chemokine utilization with regards to disease outcome. The chemokine receptor CXCR3 is upregulated in LCMV-infected CNS (Lindow et al., 2003) , and is predominately expressed on activated CD8 + T cells (Christensen et al., 2004) . During intracranial infection with LCMV (Traub), CXCR3 deficiency leads to partial protection from immunopathology and death (Christensen et al., 2004) . In immunocompetent mice infected with LCMV (Traub), CD8 + T cells preferentially traffic to the leptomeninges and choroid plexus and are also found in some parenchymal regions, such as the corpus callosum (Christensen et al., 2004) . However, in the absence of CXCR3, trafficking of these cells to specific regions was significantly delayed (Christensen et al., 2004) . This suggests that during LCMV infection, the expression of certain chemokines is necessary to target effector cells into infected CNS regions. However, this targeting, while important for viral control, may cause neuropathology. In addition, it is apparent that not only the recruitment of effector cells but the over-accumulation of the cells in infected regions of the CNS through the establishment of a CXCL10-mediated positive feedback loop may lead to immunopathology in these critical regions.
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In addition to CXCR3, other chemokine receptors may also contribute to effector T cell recruitment, since in the absence of CXCR3 only partial protection is achieved. The expression of CCR1, CCR2, and CCR5, has also been associated with meningeal inflammation (Nansen et al., 2000) . A subpopulation of activated CD8 + T cells expresses high levels of CCR2 and CCR5 (Andersson et al., 1995) . Yet, when CCR5 expression is absent there is no impairment of the LCMV-induced inflammation (Nansen et al., 2002) , supporting the notion that other chemokine receptors contribute to T cell recruitment. Overall, in addition to CXCR3, virus-activated CD8 + T cells were found to express CCR2 and CCR5, whereas activated macrophages expressed CCR1 (Nansen et al., 2000) . LCM is essentially the result of anti-viral effector T cells unable to control rapid replication of LCMV in the brain. Following viral infection, a highly potent T cell response is induced. There is a rapid and robust infiltration of effector T cells into the meninges of the CNS, which leads to increased local expression of IFN-, which leads to increased chemokine production and amplification of effector T cell infiltration. Lack of effective viral clearance contributes to persistent chemokine expression, which promotes excessive inflammation within the meninges and eventually the brain parenchyma, leading to a fatal outcome.
CXCL10/CXCR3 in human LCMV infection
One characteristic of LCMV infection in immunocompetent adults and children is the abundance of lymphocytes in the CSF (Bonthius, 2009). CD8 + T cells are thought to infiltrate into the CSF to primarily clear the virus, which subsequently leads to the symptoms of aseptic meningitis during LCMV infection (Buchmeier & Lane, 1999) . A predominant chemokine found in the CSF of patients with viral meningoencephalitis is CXCL10 (Lahrtz et al., 1997) . CXCL10 and its receptor CXCR3 have integral roles in the development of neuropathology in the mouse model of LCMV infection and may also have similar roles in the LCMV-infected CNS of certain patients. The infiltration of effector T cells into the CSF, CXCL10 expression and the resulting neuropathy are reminiscent of the mouse model, however the host factors that contribute to disease severity and, in some cases, lethality are not currently understood. Overall, chemokines appear to be important in viral control but, as seen with murine models of LCMV, also contribute to neuropathology.
HIV
Human immunodeficiency virus-1 (HIV) targets CD4 + cells and macrophages. Infection of the CNS by HIV-1 occurs in about 80% of infected individuals. HIV-1 arrives in the CNS via infected macrophages that cross the blood-brain barrier. Neurological symptoms include meningitis, encephalitis, neuropathies, and HIV-1-associated dementia (HAD), with cognitive, motor, and behavioral dysfunctions (Marcotte et al., 2003) . Chemokine involvement in HIV-1 neuropathogenesis is well recognized because of their roles in the recruitment of HIV-1 infected immune cells, inflammatory responses, and as ligands for the HIV-1 coreceptors, CXCR4 and CCR5, which are expressed by neurons and directly mediate neurotoxicity and cell death (Hesselgesser et al., 1998; Klein et al., 1999; Hosking & Lane, 2010) . Chemokines that recruit monocytes/macrophages and lymphocytes into the brain, such as CCL2, have been detected in the CSF of individuals with HIV-1 infection (Kolb et al., 1999) . CCL2 levels are significantly increased during HIV-1-induced encephalitis (HIVE) and the chemokine accumulates in the CSF and brains of patients with HAD and HIVE, as well as in macaques with Simian immunodeficiency virus (SIV)-induced encephalitis (SIVE) (Mankowski et al., 2004; Monteiro de Almeida et al., 2005; Monteiro de Almeida et al., 2006) . The expression of CCL2 in the CNS is associated with enhanced progression of HIV encephalitis, due to its ability to recruit monocytes and lymphocytes (Dhillon et al., 2008) . In addition to CCL2, CXCL10 also can attract inflammatory cells and has been detected in the CSF of HIV-1-infected patients (Kolb et al., 1999) . CXCL10 is chronically expressed within the brains of patients suffering from HIV-associated neurological disorders (Christo et al., 2009) . In addition, HIV-1 envelope glycoprotein gp120 can induce CXCL10 gene expression in astrocytes independent of IFN-(Asensio et al., 2001) . The encephalitic brain from SIVinfected animals exhibits elevated immunohistochemical expression of CCL3, CCL4, CCL5, CCL7 and CXCL10 (Sasseville et al., 1996) , suggesting a role for one or multiple chemokines in the pathogenesis of acquired immune deficiency syndrome encephalitis. Elevated levels of CCL7, another ligand for CCR2, are also detected within activated astrocytes in the brains of SIV-infected macaques, and are increased further in response to TNF-, which thus initiates neuroinvasion by SIV/HIV-infected monocytes (Renner et al., 2011) . The prevention of monocyte infiltration into the brains of HIV-infected patients is therefore a critical step in limiting the ability of the CNS to act as a viral reservoir. Chemokines may also act as neuromodulators within the HIV-infected CNS. The HIV glycoprotein gp120 may induce neuronal death via excitotoxicity during activation of CXCR4 receptors (Ohagen et al., 1999; Chen et al., 2002) and the CXCR4 ligand, CXCL12 may be converted into a neurotoxic agent via proteolytic cleavage with the resulting peptide capable of inducing neurotoxicity and apoptosis through engagement of the chemokine receptor CXCR3 (Vergote et al., 2006) . Thus, in addition to attracting inflammatory cells that contribute to neuropathology, CXCL10 can also synergize with CXCL12 cleavage products to induce neuronal cell death (van Marle et al., 2004) .
Concluding remarks
An effective anti-viral immune response is vital to maintain a balance between pathogen control and immunopathology during viral infection resolution within the CNS. While chemokines may contribute to viral clearance through focused amplification of inflammatory responses, they may also contribute to immune-mediated damage that depends on the type of virus and affected CNS compartment or region. However, targeting chemokines to abrogate all CNS infiltration may lead to untoward effects on immunosurveillance, as evidenced by the recent increase in opportunistic CNS viral infection with JC virus in patients treated with the anti-α4-integrin monoclonal antibody, natalizumab. Natalizumab treats multiple sclerosis, a chronic, inflammatory demyelinating disease, by preventing leukocyte entry at CNS endothelial barriers (Kleinschmidt-DeMasters & Tyler, 2005) . A side effect of this treatment is the occurrence of progressive multifocal leukoencephalopathy (PML), a fatal opportunistic viral infection of the CNS caused by the reactivation of latent JC virus infection (Havrdova et al., 2009) . Thus, blockade of immune cell trafficking into the CNS interferes with essential components of immune surveillance that prevent opportunistic infections. PML underscores how vital immune cell trafficking in the CNS is for monitoring and regulating immune responses. In summary, chemokines are integrally involved in recruiting targeted leukocyte populations to critical regions of the CNS that contribute both to host defense and the pathogenesis of disease. It is clear that these proinflammatory molecules exert nonredundant roles in contributing to neuroinflammation following viral infection of the CNS thus meriting further studies on chemokines with regards to viral-induced disease. Finally, it is clear that chemokines and their receptors may represent viable targets in modulating the severity of human neuroinflammatory diseases.
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